Leaderboard

En | De
No articles selected!     View Cart  
You are here: Respiratory Tract » Neoplasms 27. April 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7955  Previews Next
   
   Articles 1 - 20 / 159092  
   
A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
Future Oncol
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüro, Casarini I, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS.
PMID: 42037107 [PubMed - as supplied by publisher]


Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer.
Med Decis Making
Chen NC, Zemplenyi AT, Adamson B, Kaizer AM, O'Bryant CL, McQueen RB, Anderson KE.
PMID: 42037076 [PubMed - as supplied by publisher]


Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs. immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Chin Med J (Engl)
Huang Z, Mei S, Liu J, Zhang Q, Li Z, Jiang G, Wang F, Zhang C, Lu C, Zhang M, Chen Z, Deng Y, Xu C, Wu Y, Chang J, Feng W, Zhou Q.
PMID: 42036883 [PubMed - as supplied by publisher]


Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial.
Cancer Med
Avancini A, Belluomini L, Giannarelli D, Insolda J, Borsati A, Sposito M, Menis J, Lavagnolo P, Tregnago D, Trestini I, Schena F, Milella M, Pilotto S.
PMID: 42036773 [PubMed - indexed for MEDLINE]


CT radiomics approach to predict response to bronchial arterial chemoembolization in advanced lung cancer by multicenter study.
Sci Rep
Yang D, Tu J, Lin G, Wang Z, Lai L, Kong C, Chen W, Xia S, Lu C, Xu M, Yao H, Yu C, Chen M, Yu R, Ji J.
PMID: 42036487 [PubMed - as supplied by publisher]


Enhanced lung cancer cell inhibition using thymol nano-formulation: Design, physicochemical profiling, cytotoxic assessment, and computational interaction studies.
Biochem Biophys Res Commun
Xue Y, Chen P, Li M, Han B, He M, Sun Z.
PMID: 42035620 [PubMed - as supplied by publisher]


Impact of lung cancer diagnosis on patient lifestyle and physical activity.
Clin Transl Oncol
Marín AJ, González SC, Cruz-Castellanos P, Franco LF, Collado NR, García-Coll V, Castellanos-Montealegre M.
PMID: 42034882 [PubMed - as supplied by publisher]


Biaxially rotational noncoplanar radiotherapy vs. coplanar radiotherapy: A planning study for non-small-cell lung cancer.
Med Dosim
Tomoda R, Aoyama T, Kitagawa T, Hashimoto S, Koide Y, Tachibana H, Kodaira T.
PMID: 42034522 [PubMed - as supplied by publisher]


Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.
Respir Investig
Okazaki Y, Yoshioka H, Ikoma T, Araki K, Makihara N, Kitagawa M, Nagata Y, Fujii K, Okuno Y, Kamisako K, Nakanishi K, Ikeda Y, Yoshida K, Nakahama K, Takeyasu Y, Katsushima U, Yamanaka Y, Ikeda S, Kurata T.
PMID: 42034368 [PubMed - as supplied by publisher]


Predictive value of delta-radiomic features for the prognosis of patients with stage IA lung adenocarcinoma.
Clin Imaging
Zhong F, Li W, Lu Q, Wu L, Fang Y, Yu P, Zhao S.
PMID: 42034079 [PubMed - as supplied by publisher]


Patterns of Infection and Their Impact on Survival in Lung Cancer Patients: A Retrospective Study From Saudi Arabia.
J Epidemiol Glob Health
Abdalla H, Abaalala R, Alsaadoun N, Robaidi H, Dirar Q, Abdelfattah SI, Alkattan K, Shibl AM.
PMID: 42033628 [PubMed - as supplied by publisher]


CAR immune cell therapy strategies and advances for lung cancer.
Discov Oncol
Zheng S, Chen Y, Li R, Peng S.
PMID: 42033595 [PubMed - as supplied by publisher]


Mechanobiology of non-small cell lung cancer: bridging tumor mechanics and therapeutic strategies.
Mol Biol Rep
Joshi RD, Patil DN, Yadav KS.
PMID: 42033548 [PubMed - indexed for MEDLINE]


Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Thorac Cancer
Iida Y, Kenmotsu H, Mori K, Morita M, Sekikawa M, Yabe M, Doshita K, Miura K, Kodama H, Morikawa N, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Ohde Y, Gon Y, Takahashi T.
PMID: 42033063 [PubMed - indexed for MEDLINE]


Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
Peng Y, Zeng Y, Zhang Y, Fan D, Wang S, Deng C, Ma F, Qiu Z, Chen C, Hu Y, Hu C, Liu W, Wu F.
PMID: 42032980 [PubMed - indexed for MEDLINE]


Empirical Osimertinib as a Second-Line Treatment Is a Viable Option Following First- and Second-Generation TKI Therapy With Unknown EGFR Status in Treated Non-Small Cell Lung Cancer: A Retrospective Study.
Cancer Med
Lin MH, Chu KA, Chen CF, Jiang YC, Hong WC, Hung MY, Hsu CH.
PMID: 42032945 [PubMed - indexed for MEDLINE]


First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis.
Immunotherapy
Zhang Z, Meng K, Wu M, Li A, Yi Y, Shi C, Wan X, Tan C, Jiang Z.
PMID: 42032906 [PubMed - as supplied by publisher]


Uterine angiosarcoma diagnosed solely by endometrial biopsy and the effect of oral progesterone treatment on associated lung metastases.
BMJ Case Rep
Abu Shamleh R, Das N, Lutchman Singh K.
PMID: 42031396 [PubMed - indexed for MEDLINE]


Pseudocellulitis in a patient with non-small cell lung cancer on carboplatin, pemetrexed and pembrolizumab.
BMJ Case Rep
Beadman T, Chan MM.
PMID: 42031384 [PubMed - indexed for MEDLINE]


Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial.
J Thorac Oncol
Huang J, Chen G, Wang Z, Jin W, Zhao Y, Zhang Y, Zhuang W, Xin Y, Wang Y, Zhou J, Sun L, Jin B, Zhang G, Yao W, Yi T, Du X, Ning F, Chang J, Guo Y, Hu Y, Wang C, Ouyang W, Cai Z, Han B, Meng R, Ding Z, Su H, Li X, Yu X, Chen M, Li G, Zhang Y, Wang J, Ma R, Gong B, Cao C, Wu B, Lei C, Cao J, Zhao Y, Zhou T, Zhao S, Huang Y, Zhang L, Yang Y.
PMID: 42031067 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 159092    Page 1 of 7955  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1